Reducing the frequency and severity of auditory hallucinations: the AVATAR clinical trial

Not Applicable

Completed

• Conditions: Severe mental illness; Mental and Behavioural Disorders; Mental disorder, not otherwise specified

• Registration Number: ISRCTN65314790
• Lead Sponsor: King's College London (UK)

Brief Summary

2015 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/26269098 protocol 2018 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29175276 results 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35610590/ participant experiences (added 25/05/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-27
• Study Completion: 2016-06-01
• Last Update Posted: 6 June 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Male or female, aged 18+ who have experienced persistent auditory hallucinations despite medical treatment

Exclusion Criteria

1. Age under 18
2. Primary diagnosis of organic brain disease or substance dependency
3. Auditory hallucinations in a language not spoken by therapists

Study & Design

• Study Type: Interventional
• Study Design: Not specified